Twist Bioscience: Headwinds Are Mounting

Company Analysis - Twist Bioscience's Q3 results were relatively soft, indicating a potential moderation in growth in the coming quarters due to macroeconomic uncertainty and concerns around academic funding [1] - The company is increasing its focus on achieving profitability, which may impact its growth trajectory [1] Industry Insights - Narweena, an asset manager, focuses on identifying market dislocations caused by a poor understanding of long-term business prospects, aiming for excess risk-adjusted returns [2] - The asset manager emphasizes the importance of secular growth opportunities in markets with barriers to entry, suggesting a high risk appetite and a long-term investment horizon [2] - The aging population, low population growth, and stagnating productivity growth are expected to create a different set of investment opportunities compared to the past, with some industries facing stagnation or secular decline [2] - There is a trend towards asset-light businesses, leading to a declining need for infrastructure investments, which is driving up asset prices and compressing risk premia over time [2]